You are here: All Products  > I-Mab Announces Terms for $100 Million US IPO; Starts China Trial of Immunoncology Drug

I-Mab Announces Terms for $100 Million US IPO; Starts China Trial of Immunoncology Drug

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products